SCOPUS 정보 검색 플랫폼

Volumn 60, Issue 10, 2009, Pages 826-829

Drug-induced lupus erythematosus tumidus during treatment with adalimumab;Medikamenteninduzierter Lupus erythematodes tumidus unter Adalimumab-Therapie

(7) Sohl, S a Renner, R a Winter, U a Bodendorf, M a Paasch, U a Simon, J C a Treudler, R a

a UNIVERSITY HOSPITAL LEIPZIG (Germany)

Author keywords

Adalimumab; ANA; Biologics; Lupus erythematosus; TNF inhibitors

Indexed keywords

ADALIMUMAB; AUTOANTIBODY; CELECOXIB; DNA; HISTONE ANTIBODY; LEFLUNOMIDE;

ANAMNESIS; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; DRUG DOSE REDUCTION; HUMAN; LABORATORY TEST; LUPUS LIKE SYNDROME; RHEUMATOID ARTHRITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DRUG ERUPTIONS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS;

EID: 70350012120 PISSN: 00178470 EISSN: None Source Type: Journal
DOI: 10.1007/s00105-008-1699-4 Document Type: Article

Times cited : (14)

References (12)

1
- 34447505845
- Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases
- Ramos-Casals M, Brito-Zerón P, Muñoz S et al (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86(4):242-251
- (2007) Medicine (Baltimore) , vol.86 , Issue.4 , pp. 242-251
- Ramos-Casals M, B.¹

2
- 21744446004
- 10.1186/ar1715
- De Bandt M, Sibilia J, Le Loeët X et al 2005 Arthritis Res Ther 7 R545 10.1186/ar1715
- (2005) Arthritis Res Ther , vol.7 , pp. 545
- De Bandt, M.¹ Sibilia, J.² Le Loeët, X.³

3
- 34047260574
- Drug-induced lupus erythematosus in a patienttreated with adalumimab
- DOI 10.1016/j.jaad.2007.01.040, PII S0190962207002599
- Spillane AP, Xia Y, Sniezek PJ 2007 J Am Acad Dermatol 56 S114 17434034 10.1016/j.jaad.2007.01.040 (Pubitemid 46552083)
- (2007) Journal of the American Academy of Dermatology , vol.56
- Spillane, A.P.¹ Xia, Y.² Sniezek, P.J.³

4
- 34547734429
- Adalimumab-induced cutaneous lupus [13]
- DOI 10.1111/j.1365-2230.2007.02503.x
- Sheth N, Greenblatt D, Patel S, Acland K 2007 Clin Exp Dermatol 32 593 17692063 10.1111/j.1365-2230.2007.02503.x 1:STN:280:DC%2BD2svnsVCksw%3D%3D (Pubitemid 47231157)
- (2007) Clinical and Experimental Dermatology , vol.32 , Issue.5 , pp. 593-594
- Sheth, N.¹ Greenblatt, D.² Patel, S.³ Acland, K.⁴

5
- 44349171691
- Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents
- DOI 10.1016/j.semarthrit.2007.08.003, PII S0049017207001394
- Costa MF, Said NR, Zimmermann B 2008 Semin Arthritis Rheum 37 381 17977585 10.1016/j.semarthrit.2007.08.003 1:CAS:528:DC%2BD1cXmsFKqsb0%3D (Pubitemid 351734520)
- (2008) Seminars in Arthritis and Rheumatism , vol.37 , Issue.6 , pp. 381-387
- Costa, M.F.¹ Said, N.R.² Zimmermann, B.³

6
- 33745064418
- 16439435 10.1136/ard.2005.043166 1:CAS:528:DC%2BD28XntF2lsr8%3D
- Schiff MH, Burmester GR, Kent JD et al 2006 Ann Rheum Dis 65 889 16439435 10.1136/ard.2005.043166 1:CAS:528:DC%2BD28XntF2lsr8%3D
- (2006) Ann Rheum Dis , vol.65 , pp. 889
- Schiff, M.H.¹ Burmester, G.R.² Kent, J.D.³

7
- 0037388283
- Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis [6] (multiple letters)
- DOI 10.1002/art.11033
- Carlson E, Rothfield N 2003 Arthritis Rheum 48 1165 12687569 10.1002/art.11033 (Pubitemid 36418265)
- (2003) Arthritis and Rheumatism , vol.48 , Issue.4 , pp. 1165-1166
- Carlson, E.¹ Rothfield, N.² Pisetsky, D.S.³

8
- 36549044498
- Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFα blocking agents in rheumatoid arthritis
- DOI 10.1007/s10067-007-0728-5
- Benucci M, Saviola G, Baiardi P et al 2008 Clin Rheumatol 27 91 17929076 10.1007/s10067-007-0728-5 (Pubitemid 350182683)
- (2008) Clinical Rheumatology , vol.27 , Issue.1 , pp. 91-95
- Benucci, M.¹ Saviola, G.² Baiardi, P.³ Cammelli, E.⁴ Manfredi, M.⁵

9
- 0037116836
- Drug-induced systemic lupus erythematosus associated with etanercept therapy
- DOI 10.1016/S0140-6736(02)07714-0
- Shakoor N, Michalska M, Harris CA, Block JA (2002) Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 16;359(9306):579-580 (Pubitemid 34178442)
- (2002) Lancet , vol.359 , Issue.9306 , pp. 579-580
- Shakoor, N.¹ Michalska, M.² Harris, C.A.³ Block, J.A.⁴

10
- 0030445326
- 8996469 10.3109/03009749609065646 1:STN:280:DyaK2s7kvFKlsw%3D%3D
- Bootsma H, Spronk PE, Hummel EJ et al 1996 Scand J Rheumatol 25 352 8996469 10.3109/03009749609065646 1:STN:280:DyaK2s7kvFKlsw%3D%3D
- (1996) Scand J Rheumatol , vol.25 , pp. 352
- Bootsma, H.¹ Spronk, P.E.² Hummel, E.J.³ Al, E.⁴

11
- 37349054996
- From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis
- DOI 10.1016/j.jaad.2007.08.030, PII S0190962207013151
- Lebwohl M, Bagel J, Gelfand JM et al 2008 J Am Acad Dermatol 58 94 17980456 10.1016/j.jaad.2007.08.030 (Pubitemid 350302037)
- (2008) Journal of the American Academy of Dermatology , vol.58 , Issue.1 , pp. 94-105
- Lebwohl, M.¹ Bagel, J.² Gelfand, J.M.³ Gladman, D.⁴ Gordon, K.B.⁵ Hsu, S.⁶ Kalb, R.E.⁷ Kimball, A.B.⁸ Korman, N.J.⁹ Krueger, G.G.¹⁰ Mease, P.¹¹ Morison, W.L.¹² Paller, A.¹³ Pariser, D.M.¹⁴ Ritchlin, C.¹⁵ Strober, B.¹⁶ Van Voorhees, A.¹⁷ Weinstein, G.D.¹⁸ Young, M.¹⁹ Horn, L.²⁰ more..

12
- 34548667692
- 16869978 10.1186/ar2020
- Kapetanovic MC, Larsson L, Truedsson L et al 2006 Arthritis Res Ther 8 R131 16869978 10.1186/ar2020
- (2006) Arthritis Res Ther , vol.8 , pp. 131
- Kapetanovic, M.C.¹ Larsson, L.² Truedsson, L.³ Al, E.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.